Congestive HF 787 (14.9) 927 (36.0) 144 (20.9) 449 (20.1) 52 (15.6) Prior MI 498 (9.4) 331 (12.8) 50 (7.2) 83 (3.7) 32 (9.6) Hospitalization at baseline, n (%) 1,003 (19.0) 774 (30.0) 70 (10.1) 197 (8.8) 28 (8.4) Type of AF, n (%) First diagnosed 1,143 (21.6) 203 (7.9) 139 (20.1) 492 (22.0) 72 (21.6) Paroxysmal 2,236 (42.3) 849 (32.9) 280 (40.6) 679 (30.4) 103 (30.8) Persistent 683 (12.9) 407 (15.8) 96 (13.9) 563 (25.2) 49 (14.7) Permanent 1,212 (22.9) 1,115 (43.3) 171 (24.8) 476 (21.3) 110 (32.9) Missing 13 (0.2) 3 (0.1) 4 (0.6) 23 (1.0) 0 CHADS2 score, mean ± SD 1.8±1.2 2.3±1.3 1.9±1.2 2.3±1.3 2.1±1.1 CHA2DS2-VASc score, mean ± 3.2±1.6 3.9±1.9 3.3±1.7 3.7±1.8 3.5±1.6 SD HAS-BLED score, mean ± SD 1.9±1.0 2.0±1.2 1.6±1.0 2.1±1.2 1.6 ± 1.0
Congestive HF Prior MI 787 (14.9) 498 (9.4) 927 (36.0) 331 (12.8) 144 (20.9) 50 (7.2) 449 (20.1) 83 (3.7) 52 (15.6) 32 (9.6) Hospitalization at baseline, n (%) 1,003 (19.0) 774 (30.0) 70 (10.1) 197 (8.8) 28 (8.4) Type of AF, n (%) First diagnosed Paroxysmal Persistent Permanent Missing 1,143 (21.6) 2,236 (42.3) 683 (12.9) 1,212 (22.9) 13 (0.2) 203 (7.9) 849 (32.9) 407 (15.8) 1,115 (43.3) 3 (0.1) 139 (20.1) 280 (40.6) 96 (13.9) 171 (24.8) 4 (0.6) 492 (22.0) 679 (30.4) 563 (25.2) 476 (21.3) 23 (1.0) 72 (21.6) 103 (30.8) 49 (14.7) 110 (32.9) 0 CHADS2 score, mean ± SD 1.8±1.2 2.3±1.3 1.9±1.2 2.3±1.3 2.1±1.1 CHA2DS2-VASc score, mean ± SD 3.2±1.6 3.9±1.9 3.3±1.7 3.7±1.8 3.5±1.6 HAS-BLED score, mean ± SD 1.9±1.0 2.0±1.2 1.6±1.0 2.1±1.2 1.6 ± 1.0